Company Quick10K Filing
CTS
10-Q 2021-03-31 Filed 2021-04-29
10-K 2020-12-31 Filed 2021-02-25
10-Q 2020-09-30 Filed 2020-10-29
10-Q 2020-06-30 Filed 2020-07-31
10-Q 2020-03-31 Filed 2020-04-24
10-K 2019-12-31 Filed 2020-02-20
10-Q 2019-09-30 Filed 2019-10-24
10-Q 2019-06-30 Filed 2019-07-25
10-Q 2019-03-31 Filed 2019-04-25
10-K 2018-12-31 Filed 2019-02-22
10-Q 2018-09-30 Filed 2018-10-25
10-Q 2018-06-30 Filed 2018-07-26
10-Q 2018-03-31 Filed 2018-04-26
10-K 2017-12-31 Filed 2018-02-23
10-Q 2017-09-30 Filed 2017-10-26
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-04-27
10-K 2016-12-31 Filed 2017-02-24
10-Q 2016-09-30 Filed 2016-10-28
10-Q 2016-06-30 Filed 2016-07-29
10-Q 2016-03-31 Filed 2016-05-03
10-K 2015-12-31 Filed 2016-02-24
10-Q 2015-09-27 Filed 2015-10-27
10-Q 2015-06-28 Filed 2015-07-28
10-Q 2015-03-29 Filed 2015-04-28
10-K 2014-12-31 Filed 2015-02-24
10-Q 2014-09-28 Filed 2014-10-28
10-Q 2014-06-29 Filed 2014-07-29
10-Q 2014-03-30 Filed 2014-04-29
10-K 2013-12-31 Filed 2014-03-03
10-Q 2013-09-29 Filed 2013-10-29
10-Q 2013-06-30 Filed 2013-07-25
10-Q 2013-03-31 Filed 2013-04-25
10-K 2012-12-31 Filed 2013-02-25
10-Q 2012-09-30 Filed 2012-10-24
10-Q 2012-07-01 Filed 2012-07-24
10-Q 2012-04-01 Filed 2012-04-25
10-K 2011-12-31 Filed 2012-02-24
10-Q 2011-10-02 Filed 2011-10-26
10-Q 2011-07-03 Filed 2011-07-26
10-Q 2011-04-03 Filed 2011-04-27
10-K 2010-12-31 Filed 2011-02-24
10-Q 2010-10-03 Filed 2010-10-27
10-Q 2010-07-04 Filed 2010-07-27
10-Q 2010-04-04 Filed 2010-04-28
10-K 2009-12-31 Filed 2010-02-23
8-K 2021-02-11 Other Events, Exhibits
8-K 2021-02-09 Earnings, Exhibits
8-K 2021-02-09 Regulation FD, Exhibits
8-K 2020-12-15 Exhibits
8-K 2020-10-29
8-K 2020-10-29
8-K 2020-07-31
8-K 2020-07-31
8-K 2020-07-02
8-K 2020-05-15
8-K 2020-05-01
8-K 2020-04-24
8-K 2020-04-23
8-K 2020-04-01
8-K 2020-03-05
8-K 2020-02-04
8-K 2020-02-04
8-K 2019-11-08
8-K 2019-10-25
8-K 2019-10-24
8-K 2019-08-01
8-K 2019-07-31
8-K 2019-07-25
8-K 2019-07-25
8-K 2019-05-17
8-K 2019-05-02
8-K 2019-04-30
8-K 2019-04-29
8-K 2019-04-25
8-K 2019-02-14
8-K 2019-02-08
8-K 2019-02-05
8-K 2019-02-05
8-K 2018-12-28
8-K 2018-10-25
8-K 2018-10-25
8-K 2018-07-27
8-K 2018-07-26
8-K 2018-05-22
8-K 2018-05-18
8-K 2018-05-18
8-K 2018-04-27
8-K 2018-04-26
8-K 2018-04-04
8-K 2018-02-07
8-K 2018-02-06
8-K 2018-01-16

CTS Financials

CTS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-07-032011-10-022011-12-312012-04-012012-07-012012-09-302012-12-312013-03-312013-06-302013-09-292013-12-312014-03-302014-06-292014-09-282014-12-312015-03-292015-06-282015-09-272015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash7589768483891101098697124119127131135138147151157131120114114122108116114121103104101101106101
Accounts Receivable88908890918190949497636861635767635955656262636367657170767980828581
Inventory89919392797582828585322728302829302725262629293136353738424243434345
PP&E7982326909190334949189267747474717070697077777982838584889194979999100103
Assets495516481509490481561565529540480474480489457471489489484540520514518528538543540549543550548574581648
Accounts Payable77798075665968687172474444454344463940444243404243454952525252535148
Long-Term Debt2515475
Liabilities210225218244225209293295267270184172174177167178184193202252217207200202202197196193179173170187185253
Stockholders' Equity286291263265265272268270262270297302305312290293306296282288303306318326336347344356364376378387396395
Income Statement ($MM)2011-07-032011-10-022011-12-312012-04-012012-07-012012-09-302012-12-312013-03-312013-06-302013-09-292013-12-312014-03-302014-06-292014-09-282014-12-312015-03-292015-06-282015-09-272015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1471461441471551371381501641601021011031001009810091939799100102100106106111114118119120118121116
Cost of Revenue111726763636463666670697875767777777979
Gross Profit27303330333437363436383338424243414137
R&D555664568656566556666666667767767
SG&A18181719201922212321714161416161513141516161515161625172018181718
Tax12212221124243423-8-21358834446445344
Net Income46623694-117-35687919-5-148144881010-14127101811123
Cash Flow ($MM)2011-07-032011-10-022011-12-312012-04-012012-07-012012-09-302012-12-312013-03-312013-06-302013-09-292013-12-312014-03-302014-06-292014-09-282014-12-312015-03-292015-06-282015-09-272015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating59-4161317-3141512-61651701591501318161013241120815101517
Cash Investing-4-3-19-3-3-50-5-4-273-1-3-3-1-1-3-1-4-767-7-6-4-25-2-6-7-8-6-5-4-79
Cash Financing13-1931-15-4549-34-3-581-51-134-4-4-350-32-16-112-3-13-7-5-18-8-5-558